Tag: newer

COVID shots for JN.1 variant neutralize newer strains, vaccine makers say

(Reuters) – COVID-19 vaccine makers said data from animals studies showed their 2024-25 shots targeting the JN.1 variant that was dominant earlier this year could neutralize newer subvariants such as KP.2 much better than the older shots. This was disclosed in presentations by the companies ahead of a meeting of the U.S. Food and Drug […]